Skip to main content
Premium Trial:

Request an Annual Quote

CareDx: Michael Bell, Marcel Konrad

CareDx said that CFO Michael Bell has notified the company of his intent to resign, effective Dec. 31. The firm has appointed Marcel Konrad to serve as interim CFO, effective upon Bell's resignation. 

Konrad has served as vice president and corporate controller at CareDx since August 2018. Prior to joining the company, he served in various capacities at Santen between November 2013 and July 2018, including as CFO for Santen USA, and as global head of R&D finance and CFO for Santen Ventures. Prior to that, Konrad worked for Novartis for nine years in both Switzerland and the US in various roles. 

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.